Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders.
Katie L Davis-AndersonSebastian BergerEmilie R Lunde-YoungVishal D NaikHeewon SeoGreg A JohnsonHanno SteenJayanth RamadossPublished in: Alcoholism, clinical and experimental research (2017)
We conclude that the placenta is a valuable organ not only to understand FASD etiology but it may also serve as a diagnostic tool to identify novel biomarkers for detecting the outcome of fetal alcohol exposure. Placental MS analysis can offer sophisticated insights into identifying alcohol metabolism-related enzymes and regulators of fetal development.